Ascend Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ascend Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-220,000	Closed	-$3.33M	–	227
2014 Q1	$3.33M	Sell	220,000 -110,000	-33%	-$1.24M	0.09%	159
2013 Q4	$2.52M	Buy	+330,000	New	+$1.78M	0.08%	161

Other funds holding HZNP

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return